Abstract
Background The 2021 human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) global report indicated that women and girls in sub-Saharan Africa remained the most affected groups, accounting for 62% of new infections in the region. In 2021 in Mozambique, the HIV prevalence rate among the adult population was 12.5%, with a rate of 15.4% among women of reproductive age. Our study assessed HIV prevalence and associated factors among married women in Mozambique.
Methodology A cross-sectional epidemiological study was carried out using secondary data extracted from the 2015 Immunization, Malaria and HIV/AIDS (IMASIDA) survey in Mozambique. Married women (civil marriage and common law marriage) of reproductive age (15-49 years) were included. We applied sample weights for data analysis.
Results Out of the 3,006 married women included in the study, 20.1% fell within the 20-24 age group (n=603), and the average age was 30 years (SD=8.9 years). HIV prevalence was 6.9%. Factors significantly associated with HIV infection were age group 35-49 years (aOR=2.5; CI [1.3-4.6]; p=0.005) compared to age group 15-24 years, lack of formal education and primary education compared to higher education (aOR 7.7; CI [1.1-52.9], p=0.038 and aOR=9.8; CI [1.6-60.1]; p=0.014 respectively), having an uncircumcised partner (aOR=1.9; CI [1.2-3.1]; p=0.008), and having three or more lifetime sex partners compared to one sex partner (aOR=3.6; CI [2.9-7.3]; p< 0.001). Women who were in one lifelong union had a lower risk of HIV positivity compared to women who hadmore than one union (aOR=0.5; CI[0.3-0.8] p=0.005).
Conclusion The factors that contributed to a greater odds of HIV-positivity in this group of married Mozambican women were older age, low levels of education, having an uncircumcised partner and having more than one sexual partner throughout one’s lifetime. In order to have maximum effect, HIV prevention and control campaigns in Mozambique should be tailored tothese “higher-risk” populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was possible due the financial support for FELTP coordinated by the National Institute of Health of Mozambique through the PEPFAR Cooperative Agreement 5U2GGH000080.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Comitê Nacional de Bioética em Saúde (CNBS), Approval number 42/CNBS/2014
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
